The impact of plasma zinc status on the severity of prostate cancer disease

Purpose: The severity of prostate cancer (PCa), which determines the disease progression, is theorized to be a function of zinc status. Hence, this study was structured to determine the impact of zinc status on the severity and progression of PCa disease. Materials and Methods: This was a descriptiv...

Full description

Bibliographic Details
Main Authors: Victor C. Wakwe, Ehimen. P. Odum, Collins Amadi
Format: Article
Language:English
Published: Korean Urological Association 2019-05-01
Series:Investigative and Clinical Urology
Subjects:
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-60-162.pdf
_version_ 1818158407414185984
author Victor C. Wakwe
Ehimen. P. Odum
Collins Amadi
author_facet Victor C. Wakwe
Ehimen. P. Odum
Collins Amadi
author_sort Victor C. Wakwe
collection DOAJ
description Purpose: The severity of prostate cancer (PCa), which determines the disease progression, is theorized to be a function of zinc status. Hence, this study was structured to determine the impact of zinc status on the severity and progression of PCa disease. Materials and Methods: This was a descriptive cross-sectional study of 220 histologically-confirmed PCa patients and 220 age-matched controls, conducted prospectively in a Nigerian tertiary hospital. Plasma zinc, prostate-specific antigen, creatinine, fasting glucose, and estimated glomerular filtration rate were determined for both study groups. The International Society of Urological Pathology (ISUP) grades and the American Joint Committee on Cancer clinical staging were employed as indices for PCa severity (grade) and progression (stage) respectively. Results: The PCa patients had markedly reduced plasma zinc status compared to controls (cases: 9.42±3.02 µmol/L versus controls: 15.23±4.47 µmol/L; p<0.001). Low zinc status was more pronounced within the severe grade and advanced PCa disease subgroups (p<0.001). Inverse relationships existed between zinc status and ISUP grades among the entire PCa patient (p<0.001) and the categorized PCa grade and stage subgroups (p<0.001). Low zinc status had significant impact of predicting severe (crude=odds ratio [OR], 8.714; p<0.001; age-adjusted=OR, 11.152; p<0.001) and advanced (crude=OR, 17.160; p<0.001; age-adjusted=OR, 18.927; p<0.001) PCa disease. Conclusions: This study suggests that low plasma zinc status is associated with severe grade and advanced PCa disease. However, further well-designed studies with large sample sizes are warranted to confirm these associations.
first_indexed 2024-12-11T15:29:36Z
format Article
id doaj.art-e994be5f4c434c1584f542eedddc4872
institution Directory Open Access Journal
issn 2466-0493
2466-054X
language English
last_indexed 2024-12-11T15:29:36Z
publishDate 2019-05-01
publisher Korean Urological Association
record_format Article
series Investigative and Clinical Urology
spelling doaj.art-e994be5f4c434c1584f542eedddc48722022-12-22T01:00:07ZengKorean Urological AssociationInvestigative and Clinical Urology2466-04932466-054X2019-05-0160316216810.4111/icu.2019.60.3.162The impact of plasma zinc status on the severity of prostate cancer diseaseVictor C. Wakwe0Ehimen. P. Odum1Collins Amadi2Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.Purpose: The severity of prostate cancer (PCa), which determines the disease progression, is theorized to be a function of zinc status. Hence, this study was structured to determine the impact of zinc status on the severity and progression of PCa disease. Materials and Methods: This was a descriptive cross-sectional study of 220 histologically-confirmed PCa patients and 220 age-matched controls, conducted prospectively in a Nigerian tertiary hospital. Plasma zinc, prostate-specific antigen, creatinine, fasting glucose, and estimated glomerular filtration rate were determined for both study groups. The International Society of Urological Pathology (ISUP) grades and the American Joint Committee on Cancer clinical staging were employed as indices for PCa severity (grade) and progression (stage) respectively. Results: The PCa patients had markedly reduced plasma zinc status compared to controls (cases: 9.42±3.02 µmol/L versus controls: 15.23±4.47 µmol/L; p<0.001). Low zinc status was more pronounced within the severe grade and advanced PCa disease subgroups (p<0.001). Inverse relationships existed between zinc status and ISUP grades among the entire PCa patient (p<0.001) and the categorized PCa grade and stage subgroups (p<0.001). Low zinc status had significant impact of predicting severe (crude=odds ratio [OR], 8.714; p<0.001; age-adjusted=OR, 11.152; p<0.001) and advanced (crude=OR, 17.160; p<0.001; age-adjusted=OR, 18.927; p<0.001) PCa disease. Conclusions: This study suggests that low plasma zinc status is associated with severe grade and advanced PCa disease. However, further well-designed studies with large sample sizes are warranted to confirm these associations.https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-60-162.pdfNeoplasm gradingNeoplasm stagingProstatic neoplasmsZinc
spellingShingle Victor C. Wakwe
Ehimen. P. Odum
Collins Amadi
The impact of plasma zinc status on the severity of prostate cancer disease
Investigative and Clinical Urology
Neoplasm grading
Neoplasm staging
Prostatic neoplasms
Zinc
title The impact of plasma zinc status on the severity of prostate cancer disease
title_full The impact of plasma zinc status on the severity of prostate cancer disease
title_fullStr The impact of plasma zinc status on the severity of prostate cancer disease
title_full_unstemmed The impact of plasma zinc status on the severity of prostate cancer disease
title_short The impact of plasma zinc status on the severity of prostate cancer disease
title_sort impact of plasma zinc status on the severity of prostate cancer disease
topic Neoplasm grading
Neoplasm staging
Prostatic neoplasms
Zinc
url https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-60-162.pdf
work_keys_str_mv AT victorcwakwe theimpactofplasmazincstatusontheseverityofprostatecancerdisease
AT ehimenpodum theimpactofplasmazincstatusontheseverityofprostatecancerdisease
AT collinsamadi theimpactofplasmazincstatusontheseverityofprostatecancerdisease
AT victorcwakwe impactofplasmazincstatusontheseverityofprostatecancerdisease
AT ehimenpodum impactofplasmazincstatusontheseverityofprostatecancerdisease
AT collinsamadi impactofplasmazincstatusontheseverityofprostatecancerdisease